How many institutions held HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share in Q2 2020?

127 institutional investors reported HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share for Q2 2020. Use the holders table for investor-level position and value details.

Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Q: What does CUSIP 42225T107 represent in this 13F holders report?

CUSIP 42225T107 is the security identifier for HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 42225T107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 73,352,849
Total 13F shares: 33,977,864
Share change: +6,896,053
Total reported value: $991,115,334
Put/Call ratio: 33%
Price per share: $29.17
Number of holders: 127
Value change: +$212,900,758
Number of buys: 99
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 42225T107?
CUSIP 42225T107 identifies HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 42225T107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SC US (TTGP), LTD.	13F	Company	4.2%	3,089,191	$80,782,000	—	31 Mar 2020	13F
Norwest Venture Partners XI, LP	13F	Company	3.2%	2,352,091	$61,507,000	—	31 Mar 2020	13F
Norwest Venture Partners XII, LP	13F	Company	3.2%	2,352,090	$61,507,000	—	31 Mar 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.6%	1,178,704	$30,823,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.6%	1,160,941	$30,359,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.5%	1,111,437	$29,064,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	1.5%	1,088,834	$28,473,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	1.5%	1,081,773	$28,289,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.4%	1,061,939	$27,770,000	—	31 Mar 2020	13F
MARSHALL WACE, LLP	13F	Company	1.4%	1,020,358	$26,683,000	—	31 Mar 2020	13F
Clearbridge Investments, LLC	13F	Company	1.4%	1,011,568	$26,453,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	1.2%	892,889	$23,349,000	—	31 Mar 2020	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	798,466	$20,880,000	—	31 Mar 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	1.1%	774,369	$20,250,000	—	31 Mar 2020	13F
Capital International Investors	13F	Company	0.94%	692,700	$18,114,000	—	31 Mar 2020	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	0.67%	493,033	$12,893,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.65%	475,274	$12,428,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	0.58%	425,000	$11,114,000	—	31 Mar 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.5%	365,857	$9,567,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.47%	343,261	$8,976,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.47%	342,984	$8,969,000	—	31 Mar 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.45%	328,698	$8,375,000	—	31 Mar 2020	13F
Bellevue Group AG	13F	Company	0.34%	253,000	$6,616,000	—	31 Mar 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.34%	250,159	$6,541,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	0.31%	224,937	$5,882,000	—	31 Mar 2020	13F
Conestoga Capital Advisors, LLC	13F	Company	0.3%	217,342	$5,683,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.29%	214,570	$5,611,000	—	31 Mar 2020	13F
Nepsis Inc.	13F	Company	0.29%	214,441	$5,608,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.29%	211,910	$5,541,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	201,201	$5,261,000	—	31 Mar 2020	13F
Capital Research Global Investors	13F	Company	0.27%	196,200	$5,131,000	—	31 Mar 2020	13F
FRIESS ASSOCIATES LLC	13F	Company	0.27%	195,873	$5,122,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.24%	179,598	$4,696,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.21%	154,450	$4,039,000	—	31 Mar 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	0.2%	147,162	$3,848,000	—	31 Mar 2020	13F
Global Thematic Partners, LLC	13F	Company	0.2%	144,936	$3,790,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.2%	144,702	$3,783,000	—	31 Mar 2020	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	110,955	$2,959,000	—	31 Mar 2020	13F
Sepio Capital, LP	13F	Company	0.14%	100,262	$2,622,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.13%	96,776	$2,531,000	—	31 Mar 2020	13F
G2 Investment Partners Management LLC	13F	Company	0.13%	93,518	$2,445,000	—	31 Mar 2020	13F
AlpInvest Partners B.V.	13F	Company	0.11%	83,235	$2,177,000	—	31 Mar 2020	13F
SCGE MANAGEMENT, L.P.	13F	Company	0.1%	75,000	$1,961,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	71,219	$1,863,000	—	31 Mar 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.09%	62,866	$1,643,000	—	31 Mar 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.08%	58,720	$1,631,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	58,362	$1,527,000	—	31 Mar 2020	13F
TIGER GLOBAL MANAGEMENT LLC	13F	Company	0.07%	50,000	$1,308,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.06%	46,132	$1,206,000	—	31 Mar 2020	13F
MCKINLEY CAPITAL MANAGEMENT LLC	13F	Company	0.06%	42,270	$1,105,000	—	31 Mar 2020	13F

Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q2 2020

As of 30 Jun 2020, Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,977,864 shares. The largest 10 holders included NORWEST VENTURE PARTNERS XI, LP, NORWEST VENTURE PARTNERS XII, LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Capital Research Global Investors, ALLIANCEBERNSTEIN L.P., Clearbridge Investments, LLC, JANUS HENDERSON GROUP PLC, and Capital International Investors. This page lists 127 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

107

Q2 2020 holders

127

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.